Search Results - "Vanstraelen, Gaetan"

Darbepoetin‐alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial by Beguin, Yves, Maertens, Johan, Prijck, Bernard, Schots, Rik, Seidel, Laurence, Bonnet, Christophe, Hafraoui, Kaoutar, Willems, Evelyne, Vanstraelen, Gaetan, Servais, Sophie, Jaspers, Aurélie, Fillet, Georges, Baron, Frederic

“…We conducted a randomized study analyzing the impact of darbepoetin alfa (DA) administration with or without intravenous (i.v.) iron on erythroid recovery…”
Get full text

Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study by Janssens, Ann, Berneman, Zwi N., Offner, Fritz, Snauwaert, Sylvia, Mineur, Philippe, Vanstraelen, Gaetan, Meers, Stef, Spoormans, Isabelle, Bron, Dominique, Vande Broek, Isabelle, Van Bogaert, Charlotte, De Beleyr, Birgit, Smet, Ann, Nielsen, Lasse, Wapenaar, Robert, André, Marc

“…The multicenter observational BiRD study investigated the real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia (CLL),…”
Get full text

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry by Devos, Timothy, Havelange, Violaine, Theunissen, Koen, Meers, Stef, Benghiat, Fleur Samantha, Gadisseur, Alain, Vanstraelen, Gaëtan, Vellemans, Hélène, Bailly, Benjamin, Granacher, Nikki, Lewalle, Philippe, De Becker, Ann, Van Eygen, Koen, Janssen, Mia, Triffet, Agnes, Vrelust, Inge, Deeren, Dries, Mazure, Dominiek, Bekaert, Julie, Beck, Michael, Selleslag, Dominik

“…Data on clinical use of ponatinib are limited. This prospective registry aimed to evaluate outcomes of ponatinib treatment in routine practice over 3 years…”
Get full text

Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial by Jaspers, Aurélie, Baron, Frédéric, Willems, Évelyne, Seidel, Laurence, Hafraoui, Kaoutar, Vanstraelen, Gaetan, Bonnet, Christophe, Beguin, Yves

“…We conducted a prospective randomized trial to assess hemoglobin (Hb) response to recombinant human erythropoietin (rhEPO) therapy after hematopoietic cell…”
Get full text

Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation by Vanstraelen, Gaëtan, Frère, Pascale, Ngirabacu, Marie-Christine, Willems, Evelyne, Fillet, Georges, Beguin, Yves

“…In order to assess the effect of Pegfilgrastim on the duration of neutropenia and clinical outcome of patients after autologous peripheral blood stem cell…”
Get full text

Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: Low donor chimerism predicts for poor response by Vanstraelen, Gaëtan, Baron, Frédéric, Willems, Evelyne, Bonnet, Christophe, Hafraoui, Kaoutar, Frère, Pascale, Fillet, Georges, Beguin, Yves

“…After allogeneic hematopoietic stem cell transplantation with nonmyeloablative conditioning (NMHCT), many patients experience prolonged anemia and require red…”
Get full text

Results from the Belgian mantle cell lymphoma registry by Vergote, Vibeke, Janssens, Ann, André, Marc, Bonnet, Christophe, Van Hende, Vanessa, Van Den Neste, Eric, Van Eygen, Koen, Maerevoet, Marie, Pranger, Delphine, Schroyens, Wilfried, Debussche, Sarah, Maertens, Vincent, Beel, Karolien, Lemmens, Jan, Caron, Charlotte, Delrieu, Vanessa, Van Den Broeck, Isabelle, Vanstraelen, Gaetan, Jacquy, Caroline, Schauvlieghe, Liesbeth, De Samblanx, Hade, Madoe, Vincent, Meers, Stef, Boulet, Dominique, Verhoef, Gregor, Van Hoof, Achiel

“…Introduction: Mantle cell lymphoma is a B-cell non-Hodgkin's lymphoma characterized by a t(11;14), resulting in overexpression of cyclin D1. Conventional…”
Get full text

Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation by Vanstraelen, G, Baron, F, Frere, P, Hafraoui, K, Fillet, G, Beguin, Y

“…On day 30 after autologous peripheral blood stem cell transplantation (PBSCT), 20 patients were randomized to receive either erythropoietin at a dose of 500…”
Get full text

Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-κB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes by Robert, I, Aussems, M, Keutgens, A, Zhang, X, Hennuy, B, Viatour, P, Vanstraelen, G, Merville, M-P, Chapelle, J-P, de Leval, L, Lambert, F, Dejardin, E, Gothot, A, Chariot, A

“…Constitutive nuclear factor (NF)-κB activation in haematological malignancies is caused in several cases by loss of function mutations within the coding…”
Get full text

Darbepoetin-Alfa and I.V. Iron Administration after Autologous Hematopoietic Stem Cell Transplantation: A Prospective Randomized Multicenter Trial by Beguin, Yves, Maertens, Johan, De Prijck, Bernard, Schots, Rik, Frere, Pascale, Bonnet, Christophe, Hafraoui, Kaoutar, Willems, Evelyne, Vanstraelen, Gaetan, Lejeune, Marie, Theunissen, Koen, Fillet, Georges, Baron, Frederic

“…Background: We previously reported a retrospective study suggesting that erythropoietin therapy starting on day 28 after autologous HCT was highly effective to…”
Get full text

Pegfilgrastrim Compared with Filgrastim after Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation by Vanstraelen, Gaetan, Frère, Pascale, Ngirabacu, Marie-Christine, Willems, Evelyne, Fillet, Georges, Beguin, Yves

“…In order to assess the effect of Pegfilgrastim on the duration of neutropenia and clinical outcome of patients after autologous peripheral blood stem cell…”
Get full text

Safety Profile for Lenalidomide-Based and Non-Lenalidomide-Based First-Line Therapy for Multiple Myeloma in Transplant Ineligible Patients: Real-World Evidence from a European Post-Authorization Safety Study by Cavo, Michele, De Stefano, Valerio, Ramirez Payer, Angel, Wiesholzer, Martin, Tromp, Yvonne, Vanstraelen, Gaëtan, Schaedlich, Baerbel, Valentine, Richez, Dhanasiri, Sujith, Kueenburg, Elisabeth, Rosettani, Barbara, Martin, Claire, Pozzi, Stefano, Bacon, Pamela, Gamberi, Barbara

“…Real-world data can provide important information on the safety profile for recommended treatment options, but these data are collected infrequently. The…”
Get full text

Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients in Real-World Clinical Practice: Data from a Belgian Registry by Devos, Timothy, Theunissen, Koen, Benghiat, Fleur Samantha, Gadisseur, Alain, Meers, Stef, Selleslag, Dominik, Vanstraelen, Gaëtan, Zachée, Pierre, André, Marc, Lewalle, Philippe, Janssen, Mia, Schots, Rik, Van Eygen, Koen, Kentos, Alain, Lejeune, Marie, Triffet, Agnes, Vrelust, Inge, Kuipers, Carolina, Havelange, Violaine

“…Background Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) indicated for adult patients with resistant or intolerant chronic phase (CP),…”
Get full text

Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Data from a Nationwide Belgian Registry by Devos, Timothy, Havelange, Violaine, Theunissen, Koen, Meers, Stef, Benghiat, Fleur Samantha, Gadisseur, Alain, Vanstraelen, Gaëtan, André, Marc, Bailly, Benjamin, Granacher, Nikki, Lewalle, Philippe, De Becker, Ann, Van Eygen, Koen, Lejeune, Marie, Deeren, Dries, Nifosi, Gianfilippo, Triffet, Agnes, Vrelust, Inge, Bekaert, Julie, Beck, Michael, Selleslag, Dominik

“…Background Iclusig (ponatinib) is a third-generation tyrosine kinase inhibitor (TKI) indicated for adult patients with chronic, accelerated or blast phase CML…”
Get full text

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial by Lübbert, Michael, Wijermans, Pierre W, Kicinski, Michal, Chantepie, Sylvain, Van der Velden, Walter J F M, Noppeney, Richard, Griškevičius, Laimonas, Neubauer, Andreas, Crysandt, Martina, Vrhovac, Radovan, Luppi, Mario, Fuhrmann, Stephan, Audisio, Ernesta, Candoni, Anna, Legrand, Olivier, Foà, Robin, Gaidano, Gianluca, van Lammeren-Venema, Danielle, Posthuma, Eduardus F M, Hoogendoorn, Mels, Giraut, Anne, Stevens-Kroef, Marian, Jansen, Joop H, de Graaf, Aniek O, Efficace, Fabio, Ammatuna, Emanuele, Vilque, Jean-Pierre, Wäsch, Ralph, Becker, Heiko, Blijlevens, Nicole, Dührsen, Ulrich, Baron, Frédéric, Suciu, Stefan, Amadori, Sergio, Venditti, Adriano, Huls, Gerwin, Finke, Jürgen, Schaap, Nicolaas Petrus Michael, Zucenka, Andrius, Metzelder, Stephan, Jost, Edgar, Perić, Zinaida, Forghieri, Fabio, Allione, Bernadino, Martelli, Maurizio, Iori, Anna Paola, Wittnebel, Sebastian, Mengarelli, Andrea, Imovilli, Annalisa, Olivieri, Attilio, De Prijck, Bernard José Marie, van der Poel, Marjolein W.M., Junghanß, Christian, Salih, Helmut Rainer, Tafuri, Agostino, Guimarães, José Eduardo, Musso, Maurizio, De Fabritiis, Paolo, Chevallier, Patrice, Selleslag, Dominik Luc, Cascavilla, Nicola, Berneman, Zwi, Jaspers, Aurélie, Zuffa, Eliana, Vanstraelen, Gaëtan, Visani, Giuseppe, Cuijpers, Maria Louisa Henriëtte, De Becker, Ann, Mianulli, Anna Maria, Hackanson, Björn, Mihaylov, Georgi Georgiev, Martinelli, Giovanni, Paolini, Stefania, Zinzani, Pier Luigi, Henkes, Martin, Al-Ali, Haifa Kathrin, La Rosée, Paul, Chierichini, Anna, Cudillo, Laura, Specchia, Giorgina, Šimec, Njetočka Gredelj, Capalbo, Silvana Franca, Spinosa, Giuseppina, Molica, Stefano, de Jonge-Peeters, Susan Dorothé

“…Many older patients with acute myeloid leukaemia die or cannot undergo allogeneic haematopoietic stem-cell transplantation (HSCT) due to toxicity caused by…”
Get full text

Transfusions after nonmyeloablative or reduced-intensity conditioning regimens by BARON, F, VANSTRAELEN, G, BEGUIN, Y

Get full text

Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial by Willems, E, Baron, F, Baudoux, E, Wanten, N, Seidel, L, Vanbellinghen, J-F, Herens, C, Gothot, A, Frère, P, Bonnet, C, Hafraoui, K, Vanstraelen, G, Fillet, G, Beguin, Y

Get full text

Translocation (16;17)(q22;p13) is a recurrent anomaly of aneurysmal bone cysts by Herens, Christian, Thiry, Albert, Dresse, Marie Francoise, Born, Jacques, Flagothier, Caroline, Vanstraelen, Gaetan, Allington, Nanni, Bex, Vincent

“…Recently, Panoutsakopoulos et al. (1999) reported 2 cases of aneurysmal bone cysts with a recurrent (16;17)(q22;p13) translocation. We present here two…”
Get full text